Testing effectiveness (Phase 2)Active Not RecruitingNCT07280858
What this trial is testing
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.
Who this might be right for
Healthy ParticipantsSarbecovirus
SK Bioscience Co., Ltd. 368